SPRB
Spruce Biosciences
$46.99
+$1.34 (+2.94%)Oct 28, 2026
Key metrics
The numbers that frame SPRB today
- Market cap
- $135.05M
- ROIC
- 2,138.8%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $38.06
- 52wk High
- $131.54
Growth
Revenue and earnings trend for SPRB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SPRB
Is Spruce Biosciences a good buy?
No. Spruce Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Spruce Biosciences is selling at a very high price.
What is the market capitalization of SPRB?
Spruce Biosciences's market capitalization is $135.05M.
What is the 52-week high for SPRB stock?
The 52-week high for Spruce Biosciences is $131.54. The current close of $46.99 is 64.3% below that high.
What is the 52-week low for SPRB stock?
The 52-week low for Spruce Biosciences is $38.06. The current close of $46.99 is 23.5% above that low.
Does SPRB stock pay dividends?
Spruce Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SPRB?
Spruce Biosciences's Debt / Equity ratio is 0.09.